FDA Reconsiders Painkiller Training Requirements for Doctors

NBCNews.com-11 minutes ago

Patients would receive pharmacy pamphlets about the risks of opioids and drugmakers would fund optional physician training. The FDA's own panel of outside ...

Your Pharmacist Will Soon Be a Robot

Breitbart News-6 hours ago

Being a pharmacist has, for decades, been one of the most respected and highest paying jobs, but now apps and robotics now threaten to make most ...

Here’s How Congress Is Helping Big Pharma Keep Drug Prices High An Obama initiative to hold the line on spending has run into a lobbying buzzsaw.

http://www.huffingtonpost.com/entry/medicare-prescription-drug_us_57238466e4b0b49df6ab1e61

Firocoxib Study Leads to Equine Canada Rule Change

TheHorse.com-May 1, 2016

Variations in drug rules between the United States (where firocoxib is ... a series of drug positives that resulted from a contaminant present in a compounded oral ...

Oregon VMA

American Veterinary Medical Association-1 hour ago

... Food and Drug Administration's guidance document on veterinarycompounding and the Drug Enforcement Administration's restrictions on the compounding .

Imprimis Pharmaceuticals Begins Dispensing Lower Cost Alternative to Thiola® New customizable compounded tiopronin delayed-release formulations may significantly reduce costs and the number of pills cystinuria patients take daily

http://www.prnewswire.com/news-releases/imprimis-pharmaceuticals-begins-dispensing-lower-cost-alternative-to-thiola-300260518.html

Pharmakon Woes Point To Shifting Trends In Pharm Regulations

Pharmakon Woes Point To Shifting Trends In Pharm Regulations

Indiana Public Media-3 hours ago

Indiana has more than a dozen of these operations, including largercompounding operations known as outsourcing pharmacies. The Food and Drug ...

May 01, 2016 NIH Again Closes Drug Product Manufacturing Facilities and Halts Clinical Studies By Jay W. Cormier –

http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2016/05/nih-again-closes-drug-product-manufacturing-facilities-and-halts-clinical-studies.html?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+FdaLawBlog+%28FDA+Law+Blog%29

Making It A Lifestyle, L.L.C. Issues a Voluntary Nationwide Recall of 3rd Degree, Black Gold X Advanced, and Black Label X Due to the Presence of Undeclared Sibutramine and Sildenafil

04/29/2016 09:59 PM EDT

Making It A Lifestyle, L.L.C. is voluntarily recalling all lots of 3rd Degree, Black Gold X Advanced and Black Label X capsule form supplements to the consumer level. The products have been found to contain undeclared sibutramine and sildenafil.

Sale of complementary medicines unethical: Australian doctors

BioEdge-6 hours ago

Criticism is mounting in Australia about the sale of low-evidence complementary medicines in pharmacies. An ABC radio report last month censured the ...